真核细胞DNA复制
复制前复合体
原点识别复合体
染色体复制控制
回复
DNA复制
DNA复制因子CDT1
微小染色体维持
细胞生物学
生物
解旋酶
复制因子C
许可因素
DNA修复
DNA
遗传学
基因
核糖核酸
出处
期刊:Genes
[MDPI AG]
日期:2019-04-30
卷期号:10 (5): 331-331
被引量:46
标识
DOI:10.3390/genes10050331
摘要
The eukaryotic mini-chromosome maintenance (MCM) complex, composed of MCM proteins 2-7, is the core component of the replisome that acts as the DNA replicative helicase to unwind duplex DNA and initiate DNA replication. MCM10 tightly binds the cell division control protein 45 homolog (CDC45)/MCM2-7/ DNA replication complex Go-Ichi-Ni-San (GINS) (CMG) complex that stimulates CMG helicase activity. The MCM8-MCM9 complex may have a non-essential role in activating the pre-replicative complex in the gap 1 (G1) phase by recruiting cell division cycle 6 (CDC6) to the origin recognition complex (ORC). Each MCM subunit has a distinct function achieved by differential post-translational modifications (PTMs) in both DNA replication process and response to replication stress. Such PTMs include phosphorylation, ubiquitination, small ubiquitin-like modifier (SUMO)ylation, O-N-acetyl-D-glucosamine (GlcNAc)ylation, and acetylation. These PTMs have an important role in controlling replication progress and genome stability. Because MCM proteins are associated with various human diseases, they are regarded as potential targets for therapeutic development. In this review, we summarize the different PTMs of the MCM proteins, their involvement in DNA replication and disease development, and the potential therapeutic implications.
科研通智能强力驱动
Strongly Powered by AbleSci AI